Literature DB >> 25578405

Optimal Control of a Delayed SIRS Epidemic Model with Vaccination and Treatment.

Hassan Laarabi1, Abdelhadi Abta, Khalid Hattaf.   

Abstract

This article deals with optimal control applied to vaccination and treatment strategies for an SIRS epidemic model with logistic growth and delay. The delay is incorporated into the model in order to modeled the latent period or incubation period. The existence for the optimal control pair is also proved. Pontryagin's maximum principle with delay is used to characterize these optimal controls. The optimality system is derived and then solved numerically using an algorithm based on the forward and backward difference approximation.

Mesh:

Year:  2015        PMID: 25578405     DOI: 10.1007/s10441-015-9244-1

Source DB:  PubMed          Journal:  Acta Biotheor        ISSN: 0001-5342            Impact factor:   1.774


  5 in total

1.  Optimal control therapy and vaccination for special HIV-1 model with delay.

Authors:  Elham Shamsara; Jamal Shamsara; Zahra Afsharnezhad
Journal:  Theory Biosci       Date:  2016-08-03       Impact factor: 1.919

2.  Mathematical Analysis and Treatment for a Delayed Hepatitis B Viral Infection Model with the Adaptive Immune Response and DNA-Containing Capsids.

Authors:  Jaouad Danane; Karam Allali
Journal:  High Throughput       Date:  2018-11-19

3.  Numerical treatment on the new fractional-order SIDARTHE COVID-19 pandemic differential model via neural networks.

Authors:  Ayse Nur Akkilic; Zulqurnain Sabir; Muhammad Asif Zahoor Raja; Hasan Bulut
Journal:  Eur Phys J Plus       Date:  2022-03-11       Impact factor: 3.758

4.  Optimal control of the SIR model with constrained policy, with an application to COVID-19.

Authors:  Yujia Ding; Henry Schellhorn
Journal:  Math Biosci       Date:  2021-12-16       Impact factor: 2.144

5.  Global stability analysis of an SVEIR epidemic model with general incidence rate.

Authors:  Da-Peng Gao; Nan-Jing Huang; Shin Min Kang; Cong Zhang
Journal:  Bound Value Probl       Date:  2018-03-27       Impact factor: 2.075

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.